Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
Authors
Keywords
-
Journal
Pathogens
Volume 9, Issue 10, Pages 855
Publisher
MDPI AG
Online
2020-10-21
DOI
10.3390/pathogens9100855
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis
- (2020) Aikaterini Lalatsa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis
- (2019) Tauane G. Soyer et al. EXPERIMENTAL PARASITOLOGY
- Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis
- (2019) Iasmin Aparecida Cunha Araújo et al. EXPERIMENTAL PARASITOLOGY
- Current and emerging medications for the treatment of leishmaniasis
- (2019) Jaya Chakravarty et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy
- (2019) Alti Dayakar et al. Frontiers in Immunology
- Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
- (2019) Mahshid Mostafavi et al. BIOMEDICINE & PHARMACOTHERAPY
- Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale
- (2019) Raquel Fernández-García et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapy
- (2019) Valnês S. Rodrigues-Junior et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Effect of phospholipase A2 inhibitors during infection caused by Leishmania (Leishmania) amazonensis
- (2018) Maria L. A. C. Bordon et al. JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
- Conventional Versus Natural Alternative Treatments for Leishmaniasis: A Review
- (2018) Luiz Felipe Domingues Passero et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Distinct Roles for CD4+ Foxp3+ Regulatory T Cells and IL-10–Mediated Immunoregulatory Mechanisms during Experimental Visceral Leishmaniasis Caused by Leishmania donovani
- (2018) Patrick T. Bunn et al. JOURNAL OF IMMUNOLOGY
- Leishmaniasis: treatment, drug resistance and emerging therapies
- (2018) Shyam Sundar et al. Expert Opinion on Orphan Drugs
- Chemotherapy of leishmaniasis: present challenges
- (2017) SILVIA R. B. ULIANA et al. PARASITOLOGY
- Leishmaniasis in humans: drug or vaccine therapy?
- (2017) Masoud Ghorbani et al. Drug Design Development and Therapy
- Corrigendum to “Therapeutic effect of ursolic acid in experimental visceral leishmaniasis” [Int. J. Parasitol. Drugs Drug Resist. 7 (2017) 1–11]
- (2017) Jessica A. Jesus et al. International Journal for Parasitology-Drugs and Drug Resistance
- Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection withLeishmania amazonensis
- (2016) Cristiana T. Trinconi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ursolic acid (UA): A metabolite with promising therapeutic potential
- (2016) Dharambir Kashyap et al. LIFE SCIENCES
- Combinations of ascaridole, carvacrol, and caryophyllene oxide against Leishmania
- (2015) Jacinta Pastor et al. ACTA TROPICA
- Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents
- (2015) Haijun Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis
- (2015) Eduardo S. Yamamoto et al. PLoS One
- Leishmanicidal Triterpenes fromLantana camara
- (2014) Sabira Begum et al. CHEMISTRY & BIODIVERSITY
- Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis
- (2014) M. J. Corral et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- Treatment with triterpenic fraction purified from Baccharis uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice
- (2013) Eduardo Seiji Yamamoto et al. PARASITOLOGY RESEARCH
- Leishmania donovani Infection Induces Anemia in Hamsters by Differentially Altering Erythropoiesis in Bone Marrow and Spleen
- (2013) William P. Lafuse et al. PLoS One
- A Review of Preventative Methods against Human Leishmaniasis Infection
- (2013) Lisa Stockdale et al. PLoS Neglected Tropical Diseases
- Interferon Gamma in Leishmaniasis
- (2013) Peter E. Kima et al. Frontiers in Immunology
- Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice
- (2012) Joseane Lima Prado Godinho et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
- (2012) T. P. C. Dorlo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
- (2012) Jacques Banchereau et al. NATURE IMMUNOLOGY
- Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World
- (2011) Luiz F. Oliveira et al. ACTA TROPICA
- Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
- (2011) Shyam Sundar et al. LANCET
- Betulin and ursolic acid synthetic derivatives as inhibitors of Papilloma virus
- (2010) Oxana B. Kazakova et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Combination therapy for visceral leishmaniasis
- (2010) Johan van Griensven et al. LANCET INFECTIOUS DISEASES
- Genotoxic effects of the antileishmanial drug glucantime®
- (2009) Mayara Ingrid Sousa Lima et al. ARCHIVES OF TOXICOLOGY
- Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-γ production
- (2009) Lúcio Roberto Castellano et al. HUMAN IMMUNOLOGY
- New Treatment Approach in Indian Visceral Leishmaniasis: Single‐Dose Liposomal Amphotericin B Followed by Short‐Course Oral Miltefosine
- (2008) Shyam Sundar et al. CLINICAL INFECTIOUS DISEASES
- Triterpene acids isolated fromLagerstroemia speciosaleaves asα-glucosidase inhibitors
- (2008) Wenli Hou et al. PHYTOTHERAPY RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now